scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Gland Pharma Ltd

Feedback
Gland Pharma Ltd

Gland Pharma Ltd (GLAND) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 161,603
Mar 12, 2025 15:57 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,579.10
₹-30.45 (-1.89%)
₹1552.55 Low
Today’s Performance
₹1619.7 High
₹1411.1 Low
52 Week’s Performance
₹2220.95 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.89%
  • 1 Week 5.72%
  • 1 Month 10.87%
  • 3 Months -9.34%
  • 6 Months -14.76%
  • 1 Year -8.17%
  • 3 Years -21.52%
  • 5 Years -2.42%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 0.71
  • 52-Week Low (₹) 1,411.10
  • 52-Week High (₹) 2,220.95
  • Price-to-Book (X)* 3.02
  • Dividend Yield (%) 1.24
  • Price-to-Earnings (P/E) (X)* 37.65
  • Earnings Per Share (₹) 42.75
  • Sector Price Earning (X)* 32.47
  • Market Cap (₹ Cr.)* 26,518.37
  • * Vaues as of last close price

COMPETITORS

BT TV

Elon’s Big Starlink Win In India: How Musk Overcame Ambani, 3:05 Elon’s Big Starlink Win in India: How Musk Overcame Ambani, Airtel, Regulators
US Trade Tariffs: How Big A Threat To India And Emerging Markets? Expert Analysis 2:14 US Trade Tariffs: How Big A Threat To India And Emerging Markets? Expert Analysis
Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today 46:53 Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
CM Rekha Gupta: "Modi Ji Said CM’s Role Is For Work, Not Just Ceremonies" 2:34 CM Rekha Gupta: "Modi Ji Said CM’s Role Is For Work, Not Just Ceremonies"
Nirmala Sitharaman Slams DMK Over Tamil Language Controversy: ‘Look At Their Hypocrisy’ 0:48 Nirmala Sitharaman Slams DMK Over Tamil Language Controversy: ‘Look At Their Hypocrisy’
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Jan 25, 2024 PURCHASE
SOCIETE GENERALE
  • Qty 257761
  • Average Price ₹1,936.95
Jan 25, 2024 Sell
BNP PARIBAS ARBITRAGE
  • Qty 257761
  • Average Price ₹1,936.95
Sep 02, 2021 PURCHASE
GOLDMAN SACHS FUNDS GOLDMAN SACHS INDIA EQUITY PORTFOLIO
  • Qty 400293
  • Average Price ₹3,903.05
Sep 02, 2021 Sell
GOLDMAN SACHS INDIA FUND LIMITED
  • Qty 400293
  • Average Price ₹3,903.05
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jun 19, 2024 Sell
FOSUN PHARMA INDUSTRIAL PTE. LTD.
  • Qty 9900000
  • Average Price ₹1,771.81
Jun 19, 2024 PURCHASE
UBS PRINCIPAL CAPITAL ASIA LIMITED
  • Qty 825000
  • Average Price ₹1,771.05
Aug 09, 2023 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 1110300
  • Average Price ₹1,700.02
Aug 09, 2023 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 1110300
  • Average Price ₹1,698.72
May 22, 2023 Sell
MORGAN STANLEY INVESTMENT FUNDS EMERGING MARKETS EQUITY FUND
  • Qty 960271
  • Average Price ₹930.69
Apr 21, 2022 Sell
NICOMAC MACHINERY PRIVATE LIMITED
  • Qty 5379343
  • Average Price ₹3,200.66
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Gland Pharma Ltd share price previously?
Gland Pharma Ltd share price was down by -1.89% from the previous closing price of ₹1,609.55.
Who are peers of Gland Pharma Ltd?
The peers of Gland Pharma Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Mankind Pharma Ltd,
Who is/are the promoter/promoters of Gland Pharma Ltd?
The promotor/promotors of Gland Pharma Ltd are Yiu Kwan Stanley Lau, SRINIVAS SADU, UDO JAHANNES VETTER, C S N Murthy, ESSAJI GOOLAM VAHANVATI, Naina Lal Kidwai, Jia Ai (Allen) Zhang, Wenjie Zhang, Wei Huang.
What has been 52-week high of Gland Pharma Ltd stocks?
The highest price of Gland Pharma Ltd stock is ₹2,220.95 in the last 52-week.
What is the share price of Gland Pharma Ltd (GLAND) today on NSE?
As on Mar 12, 2025, Gland Pharma Ltd (GLAND)’s share price on NSE is Rs 1579.1
What is the market cap of Gland Pharma Ltd (GLAND?)
The current market capitalisation of Gland Pharma Ltd (GLAND) is 26,518.37 crores
What is Gland Pharma Ltd Share symbol?
The symbol of Gland Pharma Ltd is GLAND.
What is the PE ratio of Gland Pharma Ltd (GLAND)?
The current PE ratio of Gland Pharma Ltd (GLAND) is 37.65.
What is the PB ratio of Gland Pharma Ltd (GLAND)?
The current PB ratio of Gland Pharma Ltd (GLAND) is 3.02.
Today’s High & Low share prices of Gland Pharma Ltd (GLAND) on NSE?
Today, the share price of Gland Pharma Ltd (GLAND) on NSE touched a high of Rs 1619.7 and a low of Rs 1552.55
What price did Gland Pharma Ltd (GLAND) shares open on the NSE today?
On NSE, the share price of Gland Pharma Ltd (GLAND) opened at Rs 1600
What is the 52-week high of Gland Pharma Ltd (GLAND)?
The 52-week high price of Gland Pharma Ltd (GLAND) is Rs 2220.95
What is the 52-week low of Gland Pharma Ltd (GLAND) ?
The 52-week low price of Gland Pharma Ltd (GLAND) is Rs 1411.1

ABOUT GLAND PHARMA

Gland Pharma Ltd, incorporated in the year 1978, has its registered office in Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043, 91-40-30510999, 91-40-30510800. The main industry in which Gland Pharma Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Gland Pharma Ltd is/are Deloitte Haskins & Sells. In the main management, Yiu Kwan Stanley Lau is chairman and is the company secretary for Gland Pharma Ltd.

  • YKSL Yiu Kwan Stanley Lau Chairman & Independent Directo
  • SS SRINIVAS SADU Managing Director & CEO
  • UJV UDO JAHANNES VETTER Non-Exec & Non-Independent Dir
  • CSNM C S N Murthy Independent Director
  • EGV ESSAJI GOOLAM VAHANVATI Independent Director
  • NLK Naina Lal Kidwai Independent Director
  • JA(Z Jia Ai (Allen) Zhang Non-Exec & Non-Independent Dir
  • WZ Wenjie Zhang Non Executive Director
  • WH Wei Huang Additional Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement